GS
TNDM icon

GTS Securities’s Tandem Diabetes Care TNDM Stock Holding History

GTS Securities’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,576
Closed -$406K – 4442
2024
Q2 		$386K Buy
+9,576
New +$400K ﹤0.01% 2917

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GTS Securities's TNDM Position: Q3 2024 in Review

GTS Securities sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 9,576 shares — an estimated $406K sold.

GTS Securities first reported a position in TNDM in Q2 2024 and held it in 1 quarter. The position peaked at $386K in Q2 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • GTS Securities reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • GTS Securities sold 9,576 Tandem Diabetes Care shares in Q3 2024, an estimated $406K.
  • GTS Securities first reported a position in Tandem Diabetes Care in Q2 2024 and held it in 1 quarter.
  • GTS Securities's Tandem Diabetes Care position peaked at $386K in Q2 2024.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.